The study confirmed that CMR is a strong marker for risk of heart problems, but did not prove that the scans could actually be used to guide doctors’ decisions about which people are at higher risk. For that, more studies need to be done that document whether treating poor blood flow—with available medication or procedures—in people with decreased flow as predicted by the AI model, can reduce or eliminate heart attacks and strokes.